Tetracaine Hydrochloride
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB09085 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 32 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | acrodermatitis chronica atrophicans | KG + DL |
| 2 | neonatal dermatomyositis | KG + DL |
| 3 | bronchitis | KG + DL |
| 4 | secondary interstitial lung disease specific to childhood associated with a connective tissue disease | KG + DL |
| 5 | acne keloid | KG + DL |
| 6 | hydroa vacciniforme, familial | KG + DL |
| 7 | amyopathic dermatomyositis | KG + DL |
| 8 | cauda equina syndrome | KG + DL |
| 9 | irritable bowel syndrome | KG + DL |
| 10 | pityriasis simplex | KG + DL |
| 11 | seborrheic dermatitis | KG + DL |
| 12 | exanthem (disease) | KG + DL |
| 13 | post-bacterial disorder | KG + DL |
| 14 | postinfectious vasculitis | KG + DL |
| 15 | infective urethral stricture | KG + DL |
| 16 | Chagas cardiomyopathy | KG + DL |
| 17 | post-infectious syndrome | KG + DL |
| 18 | obstructive lung disease | KG + DL |
| 19 | infection-related hemolytic uremic syndrome | KG + DL |
| 20 | otitis externa | KG + DL |
| 21 | dry eye syndrome | KG + DL |
| 22 | gastroduodenitis | KG + DL |
| 23 | obsolete neurogenic bladder (disease) | KG + DL |
| 24 | papillary conjunctivitis | KG + DL |
| 25 | rhinitis | KG + DL |
| 26 | ciliary body cancer | KG + DL |
| 27 | large intestine disease | KG + DL |
| 28 | iris neoplasm | KG + DL |
| 29 | benign neoplasm of ciliary body | KG + DL |
| 30 | gastroenteritis | KG + DL |
| 31 | small intestine disease | KG + DL |
| 32 | benign neoplasm of iris | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.